|
BR112012017994A2
|
|
liquid composition, use of a liquid composition, and, methods for preparing a liquid composition and for treating a disorder
|
|
AU2007302803A1
|
|
RNA interference against Wrap53 to treat hyperproliferative diseases
|
|
WO2007139499A1
|
|
Compounds for use as a medicament
|
|
WO2007139497A1
|
|
Levoglucosenone derivatives for the treatment of disorders such as cancer, autoimmune diseases and heart diseases.
|
|
US2007142370A1
|
|
Azabicyclooctan-3-one derivatives and use thereof
|
|
CA2519795A1
|
|
Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53
|
|
WO2004035580A1
|
|
Reactivation of wild type p53 in human tumour cells by a low molecular weight compound
|
|
CA2476825A1
|
|
Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
|
